Tag: Australia

  • Cough Diagnostics Mobile App in Clinical Trial

    22 July 2015. A smartphone app designed to diagnose the nature of a cough by the sound it makes is now being tested in a clinical trial in Australia. The app, developed in the lab of engineering professor Udantha Abeyratne at University of Queensland in Brisbane, Australia was licensed to a spin-off company from the…

  • Novartis Acquires Pain Medication Developer in $200M Deal

    29 June 2015. Global pharmaceutical company Novartis is acquiring Spinifex Pharmaceuticals Inc., a developer of new types of therapies for neuropathic pain. Spinifex reports Novartis is paying $200 million in cash for the company — based in Stamford, Connecticut and Melbourne, Australia — as well as undisclosed future milestone payments. Spinifex Pharmaceuticals develops therapies for…

  • Companies Form Fertility Treatment Technologies Alliance

    8 June 2015. An alliance of drug, genomic, and assisted fertility technology companies are collaborating on processes and standards that encourage more consistency in results from assisted reproductive treatment labs. Financial details of the Global Fertility Alliance joining Illumina, Merck, and Genea were not disclosed. The three companies aim to improve outcomes in fertility clinics…

  • Trial Shows Immunotherapy Reduces Rheumatoid Arthritis

    4 June 2015. A clinical trial of an immune system therapy shows one treatment reduces levels of harmful immune activity and joint inflammation in people with rheumatoid arthritis. The early-stage trial led by researchers at University of Queensland in Brisbane, Australia is reported yesterday in the journal Science Translational Medicine. Rheumatoid arthritis is an autoimmune disease, where…

  • Antibiotic Developer Adds $9.2 Million in Early Funds

    3 June 2015. Auspherix Limited, a start-up developer of new antibiotic drugs, raised £6 million ($US 9.2 million) in early-stage venture financing. Funding for the two year-old enterprise, located in a pharmaceutical and biotechnology incubator at Stevenage, U.K., was led by technology commercialization company Imperial Innovations plc, with earlier investor Australia’s Medical Research Commercialisation Fund.…

  • Bone Drugs Found as Possible Breast Cancer Therapy

    6 November 2014. Medical researchers at the Garvan Institute in Sydney, Australia found common drugs to treat bone loss could treat breast and other other tumors outside the skeleton. The team led by Garvan research fellow Mike Rogers, with colleagues in Scotland and the U.S., published its findings online in the journal Cancer Discovery (paid…

  • Costs to Support Stroke Survivors Stay High for 10 Years

    24 October 2014. Researchers at Monash University in Australia calculated long-term costs to stroke patients, finding the financial burden on patients and their care givers remains significant for 10 years following the stroke episode. The team led by Monash medical school professor Dominique Cadilhac reported its findings in yesterday’s issue of the journal Stroke (paid…

  • Biotech, Institutes Discover Target for Multiple Tumors

    14 August 2014. Researchers in the U.S. and Australia identified an enzyme found in a range of cancerous tumor cells, but not normal adult tissue, and tested an engineered antibody to fight that enzyme in tumors. The team from the biotechnology company KaloBios Pharmaceuticals Inc. in South San Francisco, California, and Monash University and Ludwig…

  • Regeneron, Avalanche to Partner on Eye Disorder Gene Therapy

    5 May 2014. Regeneron Pharmaceuticals in Tarrytown, New York is licensing gene therapy technology from Avalanche  Biotechnologies in Menlo Park, California to develop and commercialize new treatments for eye diseases. The value of the deal is at least $640 million, but not all payment amounts were disclosed. Regeneron is a biopharmaceutical company developing therapies for inflammation, cardiovascular and metabolic disorders, cancer,…

  • Simple, Low-Cost Method Adds Microscope Lens to Smartphone

    25 April 2014. Engineers at Australian National University in Canberra devised an inexpensive process to make an add-on lens that turns a smartphone into a high-powered microscope. The team led by ANU’s Woei Ming (Steve) Lee published its technique in the May 2014 issue of the journal Biomedical Optics Express. The university filed for a…